Wolin Steven
Known title: Chief Operating OfficerCIK: 0002021524
Associated companies
Transaction History
| OSCR | ▼ Sell | Open Market | 19,227 | $347K | 12/2/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 353 | $7K | 12/2/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 6,033 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,483 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,897 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 24,671 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 2,920 | — | 12/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,460 | — | 12/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 5,141 | $90K | 9/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 4,196 | $75K | 9/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 10,242 | $184K | 9/3/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,482 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 2,920 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 24,671 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,896 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 6,034 | — | 9/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,460 | — | 9/1/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 486 | $9K | 6/4/2024 | View on chart |
| OSCR | ▼ Sell | Open Market | 18,607 | $362K | 6/3/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,897 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,460 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 6,033 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 24,671 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 2,920 | — | 6/1/2024 | View on chart |
| OSCR | ▲ Buy | Option Exercise | 1,483 | — | 6/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.